Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
- Cambridge Epigenetix
- Citibase Cambridge, Sheraton House
- Castle Park
- Cambridge , CB3 0AX
- UNITED KINGDOM
Cambridge Epigenetix is a biosciences company developing epigenetics research tools. It aims to develop technologies that have a significant impact on next-generation sequencing systems, methylation arrays, and targeted assays resulting in new avenues for research, pharmaceutical discovery, and diagnostics.